1. Home
  2. KMT vs IRON Comparison

KMT vs IRON Comparison

Compare KMT & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kennametal Inc.

KMT

Kennametal Inc.

HOLD

Current Price

$38.40

Market Cap

2.6B

Sector

Industrials

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$81.00

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KMT
IRON
Founded
1938
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
3.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KMT
IRON
Price
$38.40
$81.00
Analyst Decision
Hold
Strong Buy
Analyst Count
6
12
Target Price
$31.67
$110.08
AVG Volume (30 Days)
1.1M
513.8K
Earning Date
02-04-2026
02-26-2026
Dividend Yield
2.24%
N/A
EPS Growth
17.17
N/A
EPS
1.43
N/A
Revenue
$2,030,345,000.00
N/A
Revenue This Year
$9.46
N/A
Revenue Next Year
$4.64
N/A
P/E Ratio
$24.98
N/A
Revenue Growth
0.36
N/A
52 Week Low
$17.30
$30.82
52 Week High
$36.34
$99.50

Technical Indicators

Market Signals
Indicator
KMT
IRON
Relative Strength Index (RSI) 83.94 53.15
Support Level $33.97 $75.60
Resistance Level $35.10 $81.19
Average True Range (ATR) 1.17 4.00
MACD 0.19 0.83
Stochastic Oscillator 67.83 91.14

Price Performance

Historical Comparison
KMT
IRON

About KMT Kennametal Inc.

Kennametal Inc is a manufacturer of metalworking tools and wear-resistant engineered components and coatings. The company operates in two business segments; Metal Cutting and Infrastructure. It generates maximum revenue from the Metal Cutting segment. The Metal Cutting segment develops and manufactures high-performance tooling and metal cutting products and services and offers an assortment of standard and custom metal cutting solutions to diverse end markets, including aerospace, general engineering, energy, and transportation. Geographically, it derives maximum revenue from the United States and the rest from Germany, China, Canada, India, Italy, and other countries.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: